Phase II study of interval debulking surgery followed by intraperitoneal chemotherapy for advanced ovarian cancer: A Kansai Clinical Oncology Group study (KCOG9812)

Abstract Objective Intraperitoneal chemotherapy (IP) is known to be effective after optimal primary debulking surgery (PDS) for ovarian cancer (OC). Here, we conducted a phase II study to investigate its effectiveness after interval debulking surgery (IDS). Methods Thirty-seven patients with FIGO st...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gynecologic oncology 2013-01, Vol.128 (1), p.22-27
Hauptverfasser:	Tsubamoto, Hiroshi, Itani, Yoshio, Ito, Kimihiko, Kanazawa, Riichiro, Toyoda, Shinji, Takeuchi, Satoshi
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Advanced ovarian cancer Aged Antineoplastic Combined Chemotherapy Protocols - administration & dosage Combined Modality Therapy Cystadenocarcinoma, Serous - mortality Cystadenocarcinoma, Serous - pathology Cystadenocarcinoma, Serous - therapy Female Hematology, Oncology and Palliative Medicine Humans Injections, Intraperitoneal Interval debulking surgery Intraperitoneal chemotherapy Middle Aged Neoplasm Staging Obstetrics and Gynecology Ovarian Neoplasms - mortality Ovarian Neoplasms - pathology Ovarian Neoplasms - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!